Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
StemVacs exosomes
- Development stage
- Preclinical
- Lead developer
- Therapeutic Solutions International
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01
Overview
StemVacs exosomes are an investigational **exosome-based therapy** derived from Therapeutic Solutions International's StemVacs cellular immunotherapy platform. The product consists of cell-derived extracellular vesicles isolated from StemVacs cells and is being developed as an oncology immunotherapy, particularly for **glioma**. Based on the provided context, the exosomes are intended to **directly stimulate natural killer cells**, thereby enhancing innate antitumor immunity and suppressing tumor growth; preclinical studies reportedly showed regression of glioma in animal models. The program appears to be **preclinical / IND-enabling**, with the company indicating possible pursuit of a separate IND distinct from the parent StemVacs cell therapy program.
- Other names
- StemVacs exosomes
Beyond the preview
Go deeper on StemVacs exosomes.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on StemVacs exosomes.